1. Home
  2. RILYP vs VCEL Comparison

RILYP vs VCEL Comparison

Compare RILYP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo B. Riley Financial Inc.

RILYP

B. Riley Financial Inc.

HOLD

Current Price

$11.22

Market Cap

0.0

Sector

Finance

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$37.83

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RILYP
VCEL
Founded
1973
1989
Country
United States
United States
Employees
2056
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
RILYP
VCEL
Price
$11.22
$37.83
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$57.50
AVG Volume (30 Days)
38.1K
577.0K
Earning Date
01-01-0001
02-26-2026
Dividend Yield
7.03%
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
$854,383,000.00
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$147.15
Revenue Growth
N/A
14.05
52 Week Low
$1.73
$29.24
52 Week High
$20.00
$63.00

Technical Indicators

Market Signals
Indicator
RILYP
VCEL
Relative Strength Index (RSI) 67.13 50.84
Support Level $10.35 $35.85
Resistance Level $14.50 $39.07
Average True Range (ATR) 1.22 1.82
MACD 0.55 -0.07
Stochastic Oscillator 66.53 39.08

Price Performance

Historical Comparison
RILYP
VCEL

About RILYP B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: